<?xml version="1.0" encoding="UTF-8"?> 
		<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
		  <channel>
		    <image>
			<title>patentstorm.us</title>
			<width>258</width>
			<height>85</height>
			<link>http://www.patentstorm.us/</link>
			<url>http://www.patentstorm.us/images/logo.gif</url>
			</image>
					
		    <title>PatentStorm ->  Applications -> Organic compounds -- part of the class 532-570 series</title>
		    <link>http://www.patentstorm.us/rss/class/applications/rss-534.xml</link>
		    <description>Recent patent applications filings in USPTO Class 534 Organic compounds -- part of the class 532-570 series.</description>
		    <pubDate>Thu, 9 Feb 2012 15:00:11</pubDate>
		    <managingEditor>patents@patentstorm.us</managingEditor>
		    <language>en</language><item>
			         <title><![CDATA[Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors]]></title>
			         <link>http://www.patentstorm.us/applications/20120035351/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120035351</li><li><strong>Publication Date:</strong> &nbsp;2012-02-09</li><li><strong>Inventors:</strong> &nbsp;Kim, Moo-Sung; Norman, John Anthony Thomas; Perez, Melanie K.</li></ul>Sterically hindered imidazole ligands are described, along with their synthesis, which are capable of coordinating to Group 2 metals, such as: calcium, magnesium, strontium, in an eta-5 coordination mode which permits the formation of monomeric or dimeric volatile complexes.</p>
<p id="p-0002" num="0000">A compound comprising one or more polysubstituted imidazolate anions coordinated to a metal selected from the group consisting of barium, strontium, magnesium, radium or calcium or mixtures ...<br />]]></description>		         
			         <guid isPermaLink="false">20120035351</guid>
			      </item>
<item>
			         <title><![CDATA[HETEROCYCLE-AMINO ACID DERIVATIVES FOR TARGETING CANCER TISSUE AND RADIOACTIVE OR NON-RADIOACTIVE LABELED COMPOUNDS THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20120029177/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120029177</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Lee, Myung Chul; Jeong, Jae Min; Lee, Dong Soo; Chung, June Key; Shetty, Dinesh</li></ul>The present invention relates to novel amino acid derivatives containing heterocyclic chelating residues thereof; radioactive or nonradioactive metal complexes thereof; methods for preparation thereof; and apyrogenic and sterile preparative kits of the composition for targeting cancer cells.</p>
<p id="p-0002" num="0000">The compounds of the present invention can easily be taken up to cancer cells as they contain amino acid residues thereof; radioactive or nonradioactive metals can be labeled ...<br />]]></description>		         
			         <guid isPermaLink="false">20120029177</guid>
			      </item>
<item>
			         <title><![CDATA[Novel Triazene Compounds For The Treatment Of Cancer]]></title>
			         <link>http://www.patentstorm.us/applications/20120028927/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120028927</li><li><strong>Publication Date:</strong> &nbsp;2012-02-02</li><li><strong>Inventors:</strong> &nbsp;Forster, Heinz; Kalbe, Jochen; Reiter, Rudolf</li></ul>The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer ...<br />]]></description>		         
			         <guid isPermaLink="false">20120028927</guid>
			      </item>
<item>
			         <title><![CDATA[RAPID FRET-BASED DIAGNOSIS OF BACTERIAL PATHOGENS]]></title>
			         <link>http://www.patentstorm.us/applications/20120021454/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120021454</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Bikker, Floris Jacob; Kaman-Van Zanten, Wendy Esmeralda</li></ul>The invention comprises a substrate for detection of micro-organisms, wherein said substrate comprises a set of molecular markers linked, optionally with linker molecules or moeieties, to a di-, or tripeptide consisting of amino acids X1 and X2, or X1, X2 and X3, in which one of them, for example X1, is a D-amino acid and the others, for example X2 and X3, may be any D- or L-amino acid. Said substrate preferably is used for the detection of <i>Bacillus anthracis. </i>Alternatively, the ...<br />]]></description>		         
			         <guid isPermaLink="false">20120021454</guid>
			      </item>
<item>
			         <title><![CDATA[COLORED CURABLE COMPOSITION, COLOR RESIST, INK-JET INK, COLOR FILTER AND METHOD FOR PRODUCING THE SAME, SOLID-STATE IMAGE PICKUP DEVICE, IMAGE DISPLAY DEVICE, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, AND COLORANT COMPOUND AND TAUTOMER THEREOF]]></title>
			         <link>http://www.patentstorm.us/applications/20120021354/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120021354</li><li><strong>Publication Date:</strong> &nbsp;2012-01-26</li><li><strong>Inventors:</strong> &nbsp;Fujie, Yoshihiko; Kanna, Shinichi; Oota, Kazuya; Yabuki, Yoshiharu; Idei, Hiroaki; Ishiwata, Yasuhiro</li></ul>A colored curable composition including: at least one selected from the group consisting of a compound represented by the following Formula (1a) and a tautomer thereof; and at least one polymerizable compound,</p>
<p id="p-0002" num="0000">
</p>
<p id="p-0003" num="0000">wherein R<sup>11</sup>, R<sup>12</sup>, R<sup>13</sup>, R<sup>14</sup>, R<sup>15</sup>, and R<sup>16 </sup>each independently represent a hydrogen atom or a monovalent substituent; and R<sup>11 </sup>and R<sup>12</sup>, and ...<br />]]></description>		         
			         <guid isPermaLink="false">20120021354</guid>
			      </item>
<item>
			         <title><![CDATA[METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES]]></title>
			         <link>http://www.patentstorm.us/applications/20120015911/description.html</link>
			         <description><![CDATA[<ul><li><strong>Application Number:</strong> &nbsp;20120015911</li><li><strong>Publication Date:</strong> &nbsp;2012-01-19</li><li><strong>Inventors:</strong> &nbsp;Kong, Xianqi; Gervais, Francine; Levesque, Sophie; Valade, Isabelle; Wu, Xinfu; Bouzide, Abderrahim; Bachand, Benoit; Atfani, Mohamed; Delorme, Daniel; Migneault, David; Samim, Bita</li></ul>Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related ...<br />]]></description>		         
			         <guid isPermaLink="false">20120015911</guid>
			      </item>
</channel>
		</rss>
